|
biomedicina slovenica |
re="Breast" : 83
-
Templeton Arnoud; Ocaña Alberto; Šeruga Boštjan; Vera-Badillo Francisco; Carlsson Lindsay; Bedard Philippe L.; Amir Eitan
Management of small HER2 overexpressing tumours
2012 ►
-
Vardy JL; Pond Gregory Russell; Dodd Anna; Warr David; Šeruga Boštjan; Clemons Mark J; Bordeleau Louise; Goodwin Peter C; Tannock Ian
A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer
2012 ►
-
Merlo Domenico Franco; Primic-Žakelj Maja
Breast cancer incidence trends in European women aged 20-39 years at diagnosis
2012 ►
-
Ahčan Uroš; Bračun Drago; Živec Katarina; Pavlič Rok; Butala Peter
The use of 3D laser imaging and a new breast replica cast as a method to optimize autologous breast reconstruction after mastectomy
2012 ►
-
Krajc Mateja
Epidemiology of breast cancer and management of BRCA + patiens
2012 ►
-
Marolt-Mušič Maja
Breast anatomy
2012 ►
-
Hertl Kristijana
BI-RADS: breast imaging reporting and data system
2012 ►
-
Marolt-Mušič Maja
US of axilla
2012 ►
-
Kadivec Maksimiljan; Hertl Kristijana
Intervention procedures in breast and non-palpable breast lesions localizations
2012 ►
-
Žgajnar Janez
Breast symptoms: clinical point of view and what surgeon needs to know
2012 ►
-
Hertl Kristijana
Postsurgical breast imaging
2012 ►
-
Borštnar Simona
Systemic treatment of breast cancer
2012 ►
-
Marinko Tanja
Radiotherapy in breast cancer treatment
2012 ►
-
Kadivec Maksimiljan; Hertl Kristijana
Screening in Slovenia: where are we now
2012 ►
-
Cardoso F; Costa A; Norton L; Cameron D; Čufer T; Fallowfield L; Francis P; Gligorov J; Kyriakides S; Lin N
1st International consensus guidelines for advanced breast cancer (ABC 1)
2012 ►
-
Regan MM; Price KN; Giobbie-Hurder A; Thuerliman B; Gelber RD; Čufer T; Pajk B; Červek J
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
2011 ►
-
Čufer Tanja; Vrdoljak Eduard; Gaafar Rabab; Erensoy Inci; Pomberton Kristine
Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (Iressa) of docetaxel as second-line theapy in patients with advanced (stage IIIB of IV) non-small-cell lung cancer
2010 ►
-
Čufer Tanja
Barriers and challenges for academic cancer research
2010 ►
-
Čufer Tanja
Translation research on new molecular markers: an EORTC BCG experinece
2010 ►
-
Šeruga Boštjan; Amir Eitan
Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis
2010 ►
-
Borštnar Simona; Sadikov Aleksander; Možina Barbara; Čufer Tanja
High levels of uPA and PAI-1 predict a good response to anthracyclines
2010 ►
-
Španinger K; Matos E; Možina B; Borštnar S; Sytkowski AJ; Komel R; Debeljak N
Isoelectric focusing: method for detection of total erythropoietin in urine and plasma in cancer patients
2010 ►
-
But Hadžić Jasna; Bilban-Jakopin Cvetka; Hadžić Vedran
The role of radiation therapy in locally advanced breast cancer
2010 ►
-
Perhavec Andrež; Pohar-Perme Maja; Hočevar Marko; Bešić Nikola; Žgajnar Janez
Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node
2010 ►
-
Bešić Nikola; Kramarič Anja; Podnar Blaže; Perhavec Andraž; Marolt-Mušič Maja; Frković-Grazio Snježana; Žgajnar Janez
Factors correlated to successful surgical treatment of 181 non-palpable invasive breast carcinomas
2009 ►
-
Korde Larissa A; Lusa Lara; McShane Lisa; Lebowitz Peter F; Lukes LuAnne; Camphausen Kevin; Parker Joel S; Swain Sandra M; Hunter Kent; Zujewski Jo Anne
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
2009 ►
-
Snoj Nataša; Bedard Philippe L.; De Azambuja Evandro; Cardoso Fatima; Piccart Martine
Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
2009 ►
-
Golouh R; Čufer T; Sadikov A; Nussdorfer P; Usher PA; Brunner N; Schmitt M; Lesche R; Maier S; Timmermans M; Foekens JA; Martens JW
The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study
2008 ►
-
Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
2009 ►
-
Zhang Yi; Sieuwerts Anieta M; McGreevy Michelle; Casey Graham; Čufer Tanja; Paradiso Angelo; Harbeck Nadia; Span Paul N; Hicks David G; Golouh Rastko
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
2009 ►
-
Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Lindtner J; Čufer T
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
2009 ►
-
Ortmann Olaf; Čufer Tanja; Dixon J Michael; Maass Nicolai; Marchetti Paolo; Pagani Olivia; Pronzato Paolo; Semiglazov Vladimir; Spano Jean-Philippe; Vrdoljak Eduard; Wildiers Hans
Adjuvant endocrine therapy for perimenopausal women with early breast cancer
2009 ►
-
Snoj N; Čufer T
Two faces of screen detected cancers
2009 ►
-
Ravnik M; Sadikov A; Snoj N; Nussdorfer P; Čufer T
Validation of Adjuvant online on Slovenian collective of hormone receptor (HR) positive early breast cancer patients
2009 ►
-
Karina M; Čufer Tanja
Preliminary safety data of the EORTC 10994/BIG 00-01 neoadjuvant trial comparing 3 cycles of docetaxel followed by 3 cycles of epirubicin-docetaxel versus 6 cycles of FEC 100 in patients with locally advanced/inflammatory or large operable breast cancer
2006 ►
-
Golouh Rastko; Čufer Tanja; Sadikov A; Nusdorfer P; Usher P; Bruenner N; Schmitt M; Harbeck N; Lesche R; Meier S
Stathmin-1 protein expression is associated with disease recurrence in tamoxifen-treated steroid hormone receptor positive early breast cancer: an immunohistochemical study
2006 ►
-
Žgajnar J
Breast conserving surgery
2003 ►
-
Žgajnar Janez
Surgical management of nonpalpable breast lesions
2003 ►
-
Čufer Tanja; Borštnar Simona; Vrhovec Ivan
Prognostic and predictive value of the urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in operable breast cancer
2003 ►
-
Reberšek Martina; Čufer Tanja; Serša Gregor
Electrochemotherapy (ECT) with intratumoral application of cisplatin in breast cancer
2003 ►
-
Južnič-Šetina Tanja; Čufer Tanja; Borštnar Simona
Breast cancer in men: a 20 year review of 60 patients in Slovenia
2003 ►
-
Pajk Bojana; Čufer Tanja; Canney Peter; Ellis Paul; Cameron David; Blot Emmanuel; Vermorken Jan; Coleman Robert; Marreaud Sandrine; Bogaerts Jan
Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from EORTC 10001 randomized phase II trial
2008 ►
-
Berne S; Španinger K; Komel R; Debeljak N
Molecular mechanism of recombinant human erythropoietin action on cancer cells
2008 ►
-
Feldman Laurie; Jeong Jee-Yeong; Davis Kerry L; Socha Amanda L; Španinger Klemen; Sytkowski Arthur
Role of the erythropoietin receptor in breast cancer pathobiology
2008 ►
-
Debrakeleer S.; De Greve Jacques; Krajc Mateja; Sermijn E.; Fontaine C.; Goelen Guido; Bonduelle M.; Novaković Srdjan; Teugels Erik
Germline mutation of the BARD1 ankyrin domain in a non-BRCA1/2 breast cancer family
2006 ►
-
Žgajnar Janez
Digital evaluation of breast cosmesis after breast-conserving treatment: end of the beginning
2007 ►
-
Žgajnar Janez; Hočevar Marko; Podkrajšek Maja; Hertl Kristijana; Frković-Grazio Snježana; Vidmar Gaj; Bešić Nikola
Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early patients
2006 ►
-
Čufer Tanja
Chemotherapy in the adjuvant setting: goals and strategies
2005 ►
-
Piccart MJ; de Valeriola D; Dal-Lago L; de Azambuja E; Demonty G; Lebrun F; Bernard-Marty Ch; Colozza M; Čufer T
Adjuvant chemotherapy in 2005: standards and beyond
2005 ►
-
Žgajnar Janez
Sentinel lymphnode biopsy - from clinical trial to practice
2005 ►
-
Čufer Tanja
Palliative and supportive care
2005 ►
-
Primic-Žakelj Maja
Epidemiology of breast cancer: incidence and mortality trends, prevention and control
2005 ►
-
Čufer T; Piccart-Gebhart M
Adjuvant chemotherapy: standards and beyond
2005 ►
-
Borštnar S; Vrhovec I; Čufer T
High levels of uPA and PAI-1 predicts a good response to antracyclines
2004 ►
-
Juretič Antonio; Kavalar Rajko; Spagnoli Guilio C; Šarčevič Božena; Terracciano Luigi
Immunohistochemical detection of melanoma antigen E (MAGE) expression in breast carcinoma
2004 ►
-
Snoj Marko
Application of surgical gamma probe: the principles and practice
2003 ►
-
Lamovec J; Wotherspoon A; Jacquemier J
Malignant lymphoma and metastatic tumours
2003 ►
-
Žgajnar J; Bešić N; Hočevar M; Vidergar B; Hertl K; Frković-Grazio S
Radioguided occult lesions localisation (ROLL) of the nonpalpable breast lesions using reduced dose (1,8 MBq) of radioactivity
2003 ►
-
Žgajnar Janez
DCIS general strategy - multidisciplinary approach
2003 ►
-
Paridaens R; Dirix L; Beex L; Nooij MN; Čufer T; Lohrisch C; Biganzoli L; van Hoorebeeck I; Duchateau L; Lobelle JP; Piccart M
Promising results with exemestane in the first-line treatment of metastatic breast cancer: a randomized phase II EORTC trial with a tamoxifen control
2000 ►
-
Čufer Tanja
Palliative and supportive care
2003 ►
-
Žgajnar Janez
Sentinel lymphnode biopsy - from clinical trial to practice
2003 ►
-
Primic-Žakelj Maja
Epidemiology of breast cancer
2003 ►
-
Cauley Jane A; Norton Larry; Lippman Marc E; Eckert Stephen; Krueger Kathryn A; Purdie David W; Farrerons Jordi; Karasik Avraham; Mellstrom Dan; Kocijančič Andreja
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
2001 ►
-
Snoj Marko
Application of surgical gamma probe: the principles and practice
2001 ►
-
Snoj Marko
Application of surgical gamma probe: the principles and practice
2002 ►
-
Borštnar S; Vrhovec I; Svetič B; Čufer T
Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients
2002 ►
-
Bonnefoi H; Biganzoli L; Čufer T; Mauriac L; Hamilton A; Schaefer P; Picart M
An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer
2001 ►
-
Primic-Žakelj Maja
Epidemiology of breast cancer in the XXI century
2001 ►
-
Thuerlimann B; Price KN; Castiglione M; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International breast cancer study group trial 11-93
2001 ►
-
Bonetti M; Gelber RD; Goldhirsch A; Lindtner J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M; Cerar O; Šebek S; Novak J; Naglas M; Senčar M; Červek J; Čufer T
Features that predict responsiveness to chemotherapy and endocrine therapies
2001 ►
-
Robertson C; van den Donk M; Primic-Žakelj M; MacFarlane T; Boyle P
The association between induced and spontaneous abortion and risk of breast cancer in Slovenian women aged 25-54
2001 ►
-
Rakar S; Rainer S; Kovačič J
Experience with serous papillary tumors of the ovary
1983 ►
-
Kos L
Surgical treatment of recurrent cervical cancer
1983 ►
-
Rainer S
Cervical carcinoma stage I. (Score for treatment)
1983 ►
-
Čavič M; Rakar S; Kovačič J
Analysis of treatment failures in stage I and stage II carcinoma of the cervix
1983 ►
-
Kovačič J
Surgical management and integrated therapies in invasive cervical cancer
1983 ►
-
Uršič-Vrščaj Marjetka
Hormone replacement therapy in women with a history of breast cancer
1999 ►
-
Levičar N; Blejec A; Kos J; Golouh R; Vrhovec I; Frkovič-Gracio S; Lah TT
Prognostic impact of serine and cysteine proteinases and their inhibitors in breast carcinoma
1999 ►
-
Bonnefoi H; Biganzoli L; Čufer T; Hamilton A; Mauriac L; Van Hoorebeeck I; Piccart M
A feasibility study of epirubicin (E) in combination with cyclophosphamide (C) and infusional 5-fluorouracil (F-infu)(CEF-infu) as primary treatment of large operable (LO) or locally advanced/inflammatory (LA/I) breast cancer (BC)
1999 ►
-
Lah TT; Čerček M; Kos J; Lowder J; Gorodetsky E; Daskal I
Epidermal growth factor receptor (EGFR), Her-2
1996 ►
-
Lah Tamara T; Calaf Gloria; Kalman Endre; Shinde Balasahib G; Somers Robert; Estrada Sandino; Salero Enrique; Russo Jose; Daskal Ierachmiel
Cathepsins D, B, and L in transformed breast epithelial cells
1996 ►
-
Vlaisavljević V
Comparison of ultrasonographic diagnosis and cytologic analysis of cyst aspirates
1991 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics